CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
Abstract A CRISPR/Cas9 system has emerged as a powerful tool for gene editing to treat genetic mutation related diseases. Due to the complete endothelial barrier, effective delivery of the CRISPR/Cas9 system to vasculatures remains a challenge for in vivo gene editing of genetic vascular diseases es...
Main Authors: | Xiaoping Zhang, Chen Xu, Shijuan Gao, Ping Li, Yu Kong, Tiantian Li, Yulin Li, Fu‐Jian Xu, Jie Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.201900386 |
Similar Items
-
Applications of Alternative Nucleases in the Age of CRISPR/Cas9
by: Tuhin K. Guha, et al.
Published: (2017-11-01) -
Nuclease-based editing in the porcine genome : a strategy to facilitate porcine-to human xenotransplantation
by: Butler, James R.
Published: (2018) -
Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells
by: Yuanming Wang, et al.
Published: (2018-05-01) -
Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems
by: Nannan Zheng, et al.
Published: (2020-03-01) -
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
by: Giulia Maule, et al.
Published: (2020-05-01)